
    
      Our intentions are to phenotype Chronic Obstructive Pulmonary Disease (COPD) patients on the
      basis of factors that a related to (a) exacerbation frequency which will include (b) lung
      function to assess disease severity, (c) baseline therapy, (d) airway and systemic
      inflammatory markers, (e) health status, (f) gene expression, (g) airway bacterial and viral
      load and (h) co-morbidity including cardiovascular disease, diabetes and psychological
      disease, (i) psychological factors,(j) mortality, (k) nasal susceptibility to rhinovirus
      infection, (l) heart rate variability (m) exhaled hydrogen sulphide.
    
  